SymbolEXPO
NameEXPONENT INC
SectorCONSUMER DISCRETIONARY
RegionNorth America
IndustryServices-Management Consulting Services
AddressEXPONENT INC, MENLO PARK, CA 94025
Telephone650-326-9400
Fax
Email
Websitehttps://www.exponent.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0000851520
Description

Exponent Inc provides engineering and scientific consulting services on a project-by-project basis. The companys consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which accounts for the majority of revenue, provides servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.

Additional info from NASDAQ:
Exponent Inc provides engineering and scientific consulting services on a project-by-project basis. The companys consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which accounts for the majority of revenue, provides servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.

2026-07-30 22:27

Director Corrigan Catherine 🟡 adjusted position in 0 shares (1 derivative) of EXPONENT INC (EXPO) at $37.45 Transaction Date: Jul 28, 2026 | Filing ID: 000094

Read more
2026-07-30 20:05

Exponent Declares Regular Quarterly Dividend for Q3 2026 and Increases Stock Repurchase Authorization by $50 Million

Read more
2026-07-30 20:05

Exponent Reports Second Quarter 2026 Financial Results

Read more
2026-07-17 23:22

Director Corrigan Catherine 🟡 adjusted position in 1.7K shares (1 derivative) of EXPONENT INC (EXPO) at $62.78 Transaction Date: Jul 15, 2026 | Filing ID: 000092

Read more
2026-07-15 20:24

📋 CATHERINE CORRIGAN (Director) plans to sell 2K shares of EXPONENT, INC. (at $62.08 each, total $108K) Filed: Jul 15, 2026 | ID: 007106

Read more
2026-06-29 22:05

Director Corrigan Catherine 🟡 adjusted position in 0 shares (1 derivative) of EXPONENT INC (EXPO) at $25.41 Transaction Date: Jun 25, 2026 | Filing ID: 000090

Read more
2026-06-17 21:11

Director Corrigan Catherine 🟡 adjusted position in 4.1K shares (2 derivative) of EXPONENT INC (EXPO) at $57.13 Transaction Date: Jun 15, 2026 | Filing ID: 000088

Read more
2026-06-17 20:05

Exponent to Host Investor Day at Phoenix Test & Engineering Center

Read more
2026-06-15 20:59

📋 CATHERINE CORRIGAN (Director) plans to sell 4K shares of EXPONENT, INC. (at $57.08 each, total $235K) Filed: Jun 15, 2026 | ID: 006145

Read more
2026-06-10 20:05

(99% Neutral) EXPONENT INC (EXPO) Announces Regulatory Update

Read more